High expression of SHP2 predicts a promising prognosis in colorectal cancer

Background: Src homology 2 domain-containing phosphatase 2 (SHP2) is hyper-activated in some solid tumors. Previous findings suggest that the expression of SHP2 in colorectal cancer (CRC) may be associated with prognosis. However, validation with large sample data is lacking. Materials and Methods:...

Full description

Saved in:
Bibliographic Details
Main Authors: Xibo Liu, Mengyao Li, Lirong Chen, Fei Wen, Shu Zheng, Weiting Ge
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-07-01
Series:Indian Journal of Pathology and Microbiology
Subjects:
Online Access:https://journals.lww.com/10.4103/ijpm.ijpm_894_22
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591263676760064
author Xibo Liu
Mengyao Li
Lirong Chen
Fei Wen
Shu Zheng
Weiting Ge
author_facet Xibo Liu
Mengyao Li
Lirong Chen
Fei Wen
Shu Zheng
Weiting Ge
author_sort Xibo Liu
collection DOAJ
description Background: Src homology 2 domain-containing phosphatase 2 (SHP2) is hyper-activated in some solid tumors. Previous findings suggest that the expression of SHP2 in colorectal cancer (CRC) may be associated with prognosis. However, validation with large sample data is lacking. Materials and Methods: Tissue microarrays containing 860 CRCs and 197 mucosal tissues adjacent to the tumors were constructed. Immunohistochemistry was used to evaluate the expression of SHP2. Differences between SHP2 expression and clinicopathological parameters were evaluated. Kaplan–Meier survival curves and log-rank tests were used to analyze the relationships between SHP2 expression and the overall survival of patients. A Cox proportional hazard regression model was used for univariate and multivariate analyses of prognostic factors. Results: SHP2 expression in CRCs tissues was significantly higher than those in adjacent mucosal tissues (P < 0.001). SHP2 expression was related to tumor differentiation, depth of invasion, distant metastasis, vascular tumor thrombus, lymph node metastasis, and TNM classification (P < 0.05). The prognosis of the high-expression group of SHP2 was significantly better than that of the low-expression group (P = 0.008). Univariate analysis showed that the expression of SHP2 was a prognostic factor for CRC (P = 0.008). Multivariate analysis demonstrated that SHP2 remained an independent prognostic factor for CRC (P = 0.033). Conclusion: The expression of SHP2 was significantly higher in CRC tissues than in adjacent normal tissues. High expression of SHP2 was associated with a promising outcome, suggesting that SHP2 may be a favorable prognostic indicator of CRC.
format Article
id doaj-art-ce6886e29d6c49f2bb8892d71dc73e80
institution Kabale University
issn 0377-4929
0974-5130
language English
publishDate 2023-07-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Pathology and Microbiology
spelling doaj-art-ce6886e29d6c49f2bb8892d71dc73e802025-01-22T15:08:03ZengWolters Kluwer Medknow PublicationsIndian Journal of Pathology and Microbiology0377-49290974-51302023-07-01671293510.4103/ijpm.ijpm_894_22High expression of SHP2 predicts a promising prognosis in colorectal cancerXibo LiuMengyao LiLirong ChenFei WenShu ZhengWeiting GeBackground: Src homology 2 domain-containing phosphatase 2 (SHP2) is hyper-activated in some solid tumors. Previous findings suggest that the expression of SHP2 in colorectal cancer (CRC) may be associated with prognosis. However, validation with large sample data is lacking. Materials and Methods: Tissue microarrays containing 860 CRCs and 197 mucosal tissues adjacent to the tumors were constructed. Immunohistochemistry was used to evaluate the expression of SHP2. Differences between SHP2 expression and clinicopathological parameters were evaluated. Kaplan–Meier survival curves and log-rank tests were used to analyze the relationships between SHP2 expression and the overall survival of patients. A Cox proportional hazard regression model was used for univariate and multivariate analyses of prognostic factors. Results: SHP2 expression in CRCs tissues was significantly higher than those in adjacent mucosal tissues (P < 0.001). SHP2 expression was related to tumor differentiation, depth of invasion, distant metastasis, vascular tumor thrombus, lymph node metastasis, and TNM classification (P < 0.05). The prognosis of the high-expression group of SHP2 was significantly better than that of the low-expression group (P = 0.008). Univariate analysis showed that the expression of SHP2 was a prognostic factor for CRC (P = 0.008). Multivariate analysis demonstrated that SHP2 remained an independent prognostic factor for CRC (P = 0.033). Conclusion: The expression of SHP2 was significantly higher in CRC tissues than in adjacent normal tissues. High expression of SHP2 was associated with a promising outcome, suggesting that SHP2 may be a favorable prognostic indicator of CRC.https://journals.lww.com/10.4103/ijpm.ijpm_894_22colorectal neoplasmsimmunohistochemistryprognosisshp2tissue microarrays
spellingShingle Xibo Liu
Mengyao Li
Lirong Chen
Fei Wen
Shu Zheng
Weiting Ge
High expression of SHP2 predicts a promising prognosis in colorectal cancer
Indian Journal of Pathology and Microbiology
colorectal neoplasms
immunohistochemistry
prognosis
shp2
tissue microarrays
title High expression of SHP2 predicts a promising prognosis in colorectal cancer
title_full High expression of SHP2 predicts a promising prognosis in colorectal cancer
title_fullStr High expression of SHP2 predicts a promising prognosis in colorectal cancer
title_full_unstemmed High expression of SHP2 predicts a promising prognosis in colorectal cancer
title_short High expression of SHP2 predicts a promising prognosis in colorectal cancer
title_sort high expression of shp2 predicts a promising prognosis in colorectal cancer
topic colorectal neoplasms
immunohistochemistry
prognosis
shp2
tissue microarrays
url https://journals.lww.com/10.4103/ijpm.ijpm_894_22
work_keys_str_mv AT xiboliu highexpressionofshp2predictsapromisingprognosisincolorectalcancer
AT mengyaoli highexpressionofshp2predictsapromisingprognosisincolorectalcancer
AT lirongchen highexpressionofshp2predictsapromisingprognosisincolorectalcancer
AT feiwen highexpressionofshp2predictsapromisingprognosisincolorectalcancer
AT shuzheng highexpressionofshp2predictsapromisingprognosisincolorectalcancer
AT weitingge highexpressionofshp2predictsapromisingprognosisincolorectalcancer